课题基金 / 基金详情

Oxygen generating bioinks for 3D printed bone implants

Oxygen generating bioinks for 3D printed bone implants
用于 3D 打印骨植入物的产氧生物墨水
批准号:
10425405
负责人:
Su Ryon Shin
金额:
$37.87万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-17 至 2024-06-30

项目摘要

项目成果

Su Ryon Shin的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 肌肉骨骼组织损伤是美国残疾的主要原因,但 对于患有骨变性的患者来说,可行的选择只有几个。其中一个 这一领域的主要挑战是骨不连的形成,也就是骨的永久性失效。 骨折愈合。目前的治疗方法,如骨固定或植骨往往无效, 疼痛、侵入性、昂贵,且不会导致完全功能恢复。为了克服这一壮举 挑战,许多研究致力于开发工程三- 三维(3D)骨组织,通常由含有人的生物材料组成 骨髓间充质干细胞(HMSCs)用于骨形成和血管内皮细胞 队形。虽然这些方法加速了种植体的吻合,但本质上仍然是 与导致大量饥饿诱导细胞的血管前阶段有关 死亡。在这里,我们提出了一个创新的解决方案来解决这一重要问题。我们的目标是 通过开发一种可用于3D生物打印的产氧生物材料来实现这一点 带血管蒂骨移植治疗严重骨缺损。为此,我们着手探索 我们最近开发的两项技术:制氧生物材料和嵌入式 牺牲3D生物打印。为了在植入物的吻合前阶段维持细胞存活, 我们将开发含有释放氧气的分子的疏水微材料 可以通过调节微材料的疏水性来控制水解度。这些 微粒将与我们的3D可打印和骨形成纳米微粒相结合 掺入的生物材料基质(硅酸盐-纳米颗粒/GelMA) 骨髓间充质干细胞能有效地生成氧化骨,形成生物墨水。这种生物墨水 将被用作粘性介质,其中3D血管结构将使用 嵌入式生物打印;我们正在开拓的一种新的3D生物打印技术。具体来说,我们 将赋予构建物一个内皮细胞装载藻酸盐生物墨水的3D血管结构。 使用低水平的紫外光对含氧生物墨水进行交联会产生完全固体的3D 建造。一旦牺牲了内部藻酸盐结构,一个开放的3D血管网络将被 即刻形成。预加载的内皮细胞将覆盖3D网络,从而提供 功能性早期血管,将加速吻合,从而最大限度地减少植入物 血管预备期。在使用常氧和低氧培养进行深入的体外鉴定后, 我们将使用皮下和关键的缺陷来研究该结构的体内行为 模特。
英文摘要
Abstract Musculoskeletal tissue injuries are a leading cause of disability in the United States (US), yet there are only a few viable options for patients suffering from bone degeneration. One of the major challenges in this field is nonunion formation, which is the permanent failure of bone fracture healing. Current therapies such as bone fixation or bone grafting are often ineffective, painful, invasive, costly, and do not result in recovery of full function. To overcome this grand challenge, much research has been dedicated to the development of engineered three- dimensional (3D) bone tissue, which typically is composed of a biomaterial containing human mesenchymal stem cells (hMSCs) for bone formation and endothelial cells for blood vessel formation. Although these approaches accelerate implant anastomosis, it is inherently still associated with a prevascular phase that causes significant amounts of starvation induced cell death. Here, we propose an innovative solution to solve this important problem. We aim to achieve this by developing an oxygen generating biomaterial that can be used to 3D bioprint a vascularized bone implant for critical bone defect treatments. To this end, we set-out to explore two of our recently developed technologies: oxygen generating biomaterials and embedded sacrificial 3D bioprinting. To maintain cell survival during the implant’s pre-anastomosis phase, we will develop hydrophobic micromaterials containing molecules that release oxygen upon hydrolysis, which can be controlled via tuning the micromaterial’s hydrophobicity. These microparticles will be combined with our 3D printable and bone forming nanoparticle incorporated biomaterial matrix (Silicate-nanoparticles/GelMA) that is laden with human mesenchymal stem cells to effectively create an oxygenating bone forming bioink. This bioink will be used as a viscous medium in which a 3D vascular structure will be printed using embedded bioprinting; a novel 3D bioprinting technique that we are pioneering. Specifically, we will endow constructs with a 3D vascular structure of endothelial cell laden alginate bioink. Crosslinking the oxygenating bioink using low levels of UV light will yield a fully solid 3D construct. Upon sacrificing the internal alginate structure, an open 3D vascular network will be instantly formed. The pre-laden endothelial cells will coat the 3D network and thus provide a functional early vascularity that will accelerate anastomosis and thus minimize the implant’s prevascular phase. After in depth in vitro characterization using normoxic and hypoxic cultures, we will investigate the construct’s in vivo behavior using a subcutaneous and a critical defect model.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acsbiomaterials.9b01482
发表时间: 2020-01-13
期刊: ACS biomaterials science & engineering
影响因子: 5.8
作者: [Samanipour R, Wang T, Werb M, Hassannezhad H, Rangel JML, Hoorfar M, Hasan A, Lee CK, Shin SR]
通讯作者: Shin SR
DOI: 10.1016/j.tibtech.2021.01.007
发表时间: 2021-11
期刊: TRENDS IN BIOTECHNOLOGY
影响因子: 17.3
作者: [Willemen, Niels G. A., Hassan, Shabir, Gurian, Melvin, Li, Jinghang, Allijn, Iris E., Shin, Su Ryon, Leijten, Jeroen]
通讯作者: Leijten, Jeroen
DOI: 10.1002/cnma.201900146
发表时间: 2019-06
期刊: ChemNanoMat : chemistry of nanomaterials for energy, biology and more
影响因子: --
作者: [Fallahi A, Mandla S, Kerr-Phillip T, Seo J, Rodrigues RO, Jodat YA, Samanipour R, Hussain MA, Lee CK, Bae H, Khademhosseini A, Travas-Sejdic J, Shin SR]
通讯作者: Shin SR
Enzyme-Mediated Alleviation of Peroxide Toxicity in Self-Oxygenating Biomaterials.
酶介导减轻自氧化生物材料中的过氧化物毒性。
DOI: 10.1002/adhm.202102697
发表时间: 2022
期刊: Advanced healthcare materials
影响因子: 10
作者: [Willemen,NielsGA, Hassan,Shabir, Gurian,Melvin, Jasso-Salazar,MariaFernanda, Fan,Kai, Wang,Haihang, Becker,Malin, Allijn,IrisE, Bal-Öztürk,Ayça, Leijten,Jeroen, Shin,SuRyon]
通讯作者: Shin,SuRyon
共 13 条
    Suturable bioprinted vascularized muscle constructs for treatment of skeletal muscle loss
    • 批准号:
      10576353
    • 项目类别:
    • 资助金额:
      $53.1万
    • 财政年份:
      2021
    • 负责人:
      Su Ryon Shin
    • 依托单位:
    Suturable bioprinted vascularized muscle constructs for treatment of skeletal muscle loss
    • 批准号:
      10353393
    • 项目类别:
    • 资助金额:
      $53.65万
    • 财政年份:
      2021
    • 负责人:
      Su Ryon Shin
    • 依托单位:
    Programmable multimaterial bioprinting of 3D vascularized tissue constructs
    • 批准号:
      9788446
    • 项目类别:
    • 资助金额:
      $21.98万
    • 财政年份:
      2018
    • 负责人:
      Su Ryon Shin
    • 依托单位:
    Oxygen generating bioinks for 3D printed bone implants
    • 批准号:
      10212963
    • 项目类别:
    • 资助金额:
      $39.02万
    • 财政年份:
      2018
    • 负责人:
      Su Ryon Shin
    • 依托单位:
    海外基金